DHI extends decline as sellers keep control below long-term averages

DHI extends decline as sellers keep control below long-term averages
DR Horton drops 4.33% to $146.31

DR Horton (DHI) stock is trading at $146.31, down 4.33% on the day. The price sits below its key moving averages, with trading activity concentrated near today’s low and volatility running high.

DHI price prediction
24H -0.9%
$143.92
48H -0.76%
$144.12
7D -1.16%
$143.54
1M 5.31%
$152.94
3M 5.64%
$153.42
6M 0.23%
$145.56
12M -0.63%
$144.31
Current price: $145.23 -7.7000 5.03%
Closed 11/03
Daily range 144.80 Arrow from to Icon 150.53
Weekly range 140.67 Arrow from to Icon 153.52
Loading...

Highlights

  • D.R. Horton reported fourth quarter fiscal 2026 net income of $741.8 million and revenue of $9.4 billion.
  • The board raised the quarterly dividend by 11% to $0.50 per share and returned $4.1 billion to shareholders through buybacks and dividends in fiscal 2026.
  • Shares of D.R. Horton trade below key moving averages with a bearish structure and an expected range of $140.56 to $152.06 over the next 2 to 3 days.

Dividend hike and buybacks as operating strength meets selling pressure

D.R. Horton reported fourth quarter fiscal 2026 net income of $741.8 million and consolidated revenue of $9.4 billion, reflecting solid operating performance for the period. The company’s board raised the quarterly dividend by 11% to $0.50 per share, with payment set for November 19, 2026, highlighting ongoing capital returns to shareholders. In fiscal 2026, $4.1 billion was distributed through share repurchases and dividends, including $3.6 billion in stock buybacks and $513 million in dividends, according to Yahoo Finance, though price action has remained under broader selling pressure.

DR Horton Inc asset chart
DR Horton Inc price dynamics. Source: TradingView.

Divergent momentum and resistance at Kijun amid persistent weakness

The stock is trading below its MA-20, MA-50, and MA-200 on the hourly chart. The Ichimoku Kijun at $147.07 acts as immediate resistance. Momentum indicators present mixed signals: while MACD issues a Buy, ADX remains a Sell. RSI and CCI are both neutral, Stoch RSI is in the oversold zone, and Bull/Bear Power is positive at 1.12, suggesting buyers have a slight intraday edge. AO is neutral, with high volatility and divergent momentum signals mirroring today’s session losses.

Downside favored as volatility range holds with key support risk

Over the next 2 to 3 trading days, DHI is expected to fluctuate within a $140.56 to $152.06 range, representing a typical volatility band relative to current levels. The probability of a move higher stands at 41%, while a downside move is more likely at 59%. The baseline scenario sees the price holding within this corridor, with upside potential contingent on overcoming the Kijun and recent moving average resistance, and a bearish scenario developing if support at $140.56 fails, opening the door to further declines.

Anton Kharitonov, expert at Traders Union, notes that D.R. Horton’s latest earnings and capital return figures show solid fundamentals, but technical signals are bearish in the short term. He sees sellers in control, with resistance near $147.07 and heightened volatility reflecting continued downside risk. The expert believes any sustained rebound is unlikely until the price decisively reclaims key moving averages. "As long as DHI remains under $147 and support at $140.56 is at risk, I stay defensive and avoid aggressive buying."

Previously it was reported that DR Horton stock faced persistent downside momentum, with technical signals reflecting caution and the need for a break above resistance to shift the outlook. The latest update adds that, while capital returns remain strong, ongoing selling pressure and mixed momentum signals reinforce the importance of monitoring $147.07 as a near-term resistance level to gauge the next directional move.

The information is based on forecasts and does not constitute investment advice or a guarantee of future results. Market conditions may change. See our Disclaimer and Editorial Integrity for details.